Results 141 to 150 of about 13,667 (181)

Viral hemorrhagic fevers Lassa virus: (Week 38) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 23, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Lassa virus, Viral hemorrhagic fevers cases.

core  

A fractional-order analysis of recurrent Lassa fever transmission in Nigeria. [PDF]

Virus Res
Alaje AI, Adedeji JA, Olayiwola MO.
europepmc   +1 more source

Viral hemorrhagic fevers Lassa virus: (Week 52) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 30, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Lassa virus, Viral hemorrhagic fevers cases.

core  

Development and qualification of an enzyme-linked immunosorbent assay to detect human serum immunoglobulin G reactive to multiple lineages of Lassa virus nucleoprotein. [PDF]

PLoS One
Yun H, Sigei F, Appiah NYA, Quaye CNO, Yankey CAB, Kyei-Baafour E, Hayes P, Marini A, Bailer RT, Zaric M, Kusi KA.   +10 more
europepmc   +1 more source

Viral hemorrhagic fevers Lassa virus: (Week 31) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 5, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Lassa virus, Viral hemorrhagic fevers cases.

core  

Viral hemorrhagic fevers Lassa virus: (Week 19) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending May 13, 2023

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Lassa virus, Viral hemorrhagic fevers cases.

core  

Evaluation of candidate reference materials for the harmonization of Lassa fever serology. [PDF]

Emerg Microbes Infect
Bentley EM, Ithete N, Mitchell J, Richardson SAS, Bernasconi V, Killip M, Garry RF, Branco L, Günther S, Atkinson E, Rigsby P, Hinrichs M, Oestereich L, Thielebein A, Omoifo V, Omiunu R, Esumeh R, Okogbenin S, Kristiansen PA, Page M, Ogbaini-Emovon E, Mattiuzzo G, Collaborative Study Participants.   +22 more
europepmc   +1 more source

Local heterogeneity in Lassa fever serology in rural Nigeria: Implications for vaccine trial site selection. [PDF]

PLoS Negl Trop Dis
Simons D, Harden C, Imirzian N, Thompson KET, Ifebueme NM, Eziechina S, Ignatius H, Marcus D, Aderibigbe F, Koninga JT, Meremikwu M, Moses L, Redding DW, Friant S.   +13 more
europepmc   +1 more source

Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial. [PDF]

Nat Med
Ortiz JR, Kurup D, Kaufman AC, Ben Hamed S, LaRocco AM, Lyke KE, Litts SM, Datta S, Liang Y, McGilvray MF, Losignor JA, Oshinsky JJ, Palmer KV, Johnson-Mayo IP, Scher G, Balakumar U, Chandwani A, Rapaka RR, Deming ME, Chua JV, Wirblich C, Chen WH, Neuzil KM, Pasetti MF, Schnell MJ.   +24 more
europepmc   +1 more source

Infectious medical waste (IMW) and disease transmission: A critical public health challenge in Africa and the global implications - A systematic review. [PDF]

J Public Health Res
Squire JNT, George M, Allain Z, Eyawo O.
europepmc   +1 more source